World's Best Scientists 2026 revealed!
Pnina Langevitz

Pnina Langevitz

D-Index & Metrics

Immunology

D-Index
75
Citations
16455
World Ranking
2011
National Ranking
13

Medicine

D-Index
77
Citations
17020
World Ranking
18580
National Ranking
53

Pnina Langevitz publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Pnina Langevitz sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 243 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Pnina Langevitz D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Pnina Langevitz sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 75 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Pnina Langevitz is a researcher affiliated with Tel Aviv University in Israel. Their work primarily falls within the broader field of Medicine, with particular focus on several important subfields including Neurology, Infectious Diseases, Rheumatology, Animal Science and Zoology, and Epidemiology.

The main research topics covered by Langevitz include:

  • SARS-CoV-2 and COVID-19 Research
  • Animal Virus Infections Studies
  • Respiratory Viral Infections Research
  • Rheumatoid Arthritis Research and Therapies
  • Multiple Sclerosis Research Studies
  • Tryptophan and Brain Disorders
  • Systemic Lupus Erythematosus Research

Among recent publications, Langevitz has contributed to several papers across various journals. These include:

  • "Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination," published in 2021 in Vaccines
  • "The impact of tocilizumab on anxiety and depression in patients with rheumatoid arthritis," published in 2020 in the European Journal of Clinical Investigation
  • "The third dose of BNT162b2 COVID-19 vaccine is efficacious and safe for systemic lupus erythematosus patients receiving belimumab," published in 2023 in Lupus
  • "Herpes vaccine, splenectomy, and thymectomy associated with autoimmune diseases and the kaleidoscope of autoimmunity," published in 2024 in Autoimmunity Reviews

Collaborations feature frequently in Langevitz's work. Frequent coauthors include Abdulla Watad, Merav Lidar, Yehuda Shoenfeld, Howard Amital, and Gabriele De Marco. These collaborations appear repeatedly across publications, indicating an ongoing research partnership.

Langevitz's presence in multiple publication venues illustrates engagement with diverse scientific communities. These venues include:

  • Vaccines
  • European Journal of Clinical Investigation
  • Lupus
  • Autoimmunity Reviews

Best Publications

  • Criteria for the diagnosis of familial mediterranean fever

    Avi Livneh;Pnina Langevitz;Deborah Zemer;Nurit Zaks

  • Hydroxychloroquine: From Malaria to Autoimmunity

    Ilan Ben-Zvi;Shaye Kivity;Pnina Langevitz;Yehuda Shoenfeld

  • Vitamin D and autoimmune thyroid diseases

    Shaye Kivity;Nancy Agmon-Levin;Michael Zisappl;Yinon Shapira

  • Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome.

    Shai Padeh;Naphtali Brezniak;Debora Zemer;Elon Pras

  • Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination

    Abdulla Watad;Gabriele De Marco;Hussein Mahajna;Hussein Mahajna;Amit Druyan;Amit Druyan

  • Clinical differences between North African and Iraqi Jews with familial Mediterranean fever.

    Pras E;Livneh A;Balow Je;Kastner Dl

  • A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response.

    Yair Levy;Yaniv Sherer;Alaa Ahmed;Pnina Langevitz

  • MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever.

    Avi Livneh;Pnina Langevitz;Yael Shinar;Nurit Zaks

  • The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases--2008.

    Yehuda Shoenfeld;Gisele Zandman-Goddard;Ljudmila Stojanovich;Maurizio Cutolo

  • The changing face of Familial Mediterranean Fever

    Avi Livnehneh;Avi Livnehneh;Pnina Langevitz;Deborah Zemer;Deborah Zemer;Shai Padeh;Shai Padeh

  • Diagnostic and treatment concerns in familial Mediterranean fever

    Avi Livneh;Pnina Langevitz

  • Colchicine nonresponsiveness in familial mediterranean fever : Clinical, genetic, pharmacokinetic, and socioeconomic characterization

    Merav Lidar;Jean-Michel Scherrmann;Yael Shinar;Angela Chetrit

  • Low-molecular-weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies

    Mordechai Dulitzki;Rachel Pauzner;Pnina Langevitz;Mordechai Pras

  • Protracted febrile myalgia in patients with familial Mediterranean fever.

    Langevitz P;Zemer D;Livneh A;Shemer J

  • The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases--2008.

    Yehuda Shoenfeld;Miri Blank;Mahmoud Abu-Shakra;Mahmoud Abu-Shakra;Howard Amital

  • High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis.

    Carrait Rachima Maoz;Pnina Langevitz;Avi Livneh;Avi Livneh;Zvia Blumstein

  • Colchicine treatment of AA amyloidosis of familial Mediterranean fever. An analysis of factors affecting outcome.

    Avi Livneh;Deborah Zemer;Pnina Langevitz;Arie Laor

  • Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial.

    Michael H Silverman;Vibeke Strand;Doron Markovits;Menachem Nahir

  • Activation of the cytokine network in familial Mediterranean fever.

    N. Gang;J.P.H. Drenth;P. Langevitz;D. Zemer

  • Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state.

    Anna Kogan;Yael Shinar;Merav Lidar;Ani Revivo

Frequent Co-Authors

Yehuda Shoenfeld
Yehuda Shoenfeld Sheba Medical Center
Gisele Zandman-Goddard
Gisele Zandman-Goddard Wolfson Medical Center
Howard Amital
Howard Amital Sheba Medical Center
Boris Gilburd
Boris Gilburd Sheba Medical Center
Yaniv Sherer
Yaniv Sherer Ben-Gurion University of the Negev
Elon Pras
Elon Pras Tel Aviv University
Nancy Agmon-Levin
Nancy Agmon-Levin Sheba Medical Center
Miri Blank
Miri Blank Tel Aviv University
Dan Buskila
Dan Buskila Ben-Gurion University of the Negev
Dafna D. Gladman
Dafna D. Gladman Toronto Western Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, there are several complementary healthcare degree options that can expand career opportunities. Nursing pathways often intersect with immunology through patient care and medical research. Programs like the easiest ABSN program to get into offer accelerated routes for those who already hold a bachelor’s degree and want to transition into nursing swiftly.

Entry-level nursing roles can also be pursued through accredited LPN programs easy to get into, providing foundational clinical skills that are valuable in immunology-related healthcare settings. For advanced practice nurses, easiest online nurse practitioner programs provide flexibility and accessibility, enabling professionals to specialize in areas linked to immune health and infectious diseases.

Specifically, those focusing on mental health and immunology may find top online PMHNP programs with best clinical placement rates beneficial for gaining practical experience while advancing their credentials. These pathways are essential in supporting holistic approaches to immunological health and patient care.

Best Scientists Citing Pnina Langevitz

Trending Scientists

Recently Published Articles